These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 9396294

  • 1. [Constitutional delay of growth and puberty in male].
    Hirano T.
    Nihon Rinsho; 1997 Nov; 55(11):2952-7. PubMed ID: 9396294
    [Abstract] [Full Text] [Related]

  • 2. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
    Wehkalampi K, Vangonen K, Laine T, Dunkel L.
    Horm Res; 2007 Nov; 68(2):99-104. PubMed ID: 17377395
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.
    Strickland AL.
    Pediatrics; 1993 Apr; 91(4):716-20. PubMed ID: 8464656
    [Abstract] [Full Text] [Related]

  • 4. Are short boys with constitutional delay of growth and puberty candidates for rGH therapy according to FDA recommendations?
    Krajewska-Siuda E, Malecka-Tendera E, Krajewski-Siuda K.
    Horm Res; 2006 Apr; 65(4):192-6. PubMed ID: 16549932
    [Abstract] [Full Text] [Related]

  • 5. Management of children with short stature.
    O'Shea D, Byrne M, Powell D.
    Ir Med J; 1990 Mar; 83(1):25-7. PubMed ID: 2361835
    [Abstract] [Full Text] [Related]

  • 6. Adult height predictions for Constitutional Growth Delay, growth hormone treatment for idiopathic short stature and the FDA: are they related?
    Rapaport R.
    Horm Res; 2006 Mar; 65(4):197-9. PubMed ID: 16549933
    [No Abstract] [Full Text] [Related]

  • 7. Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group.
    Wilson DM, McCauley E, Brown DR, Dudley R.
    Pediatrics; 1995 Dec; 96(6):1095-100. PubMed ID: 7491227
    [Abstract] [Full Text] [Related]

  • 8. [Normal puberty and delayed puberty].
    Heinrichs C.
    Rev Med Brux; 2011 Sep; 32(4):256-62. PubMed ID: 22034755
    [Abstract] [Full Text] [Related]

  • 9. Characteristic dynamics of height and weight in preschool boys with constitutional delay of growth and puberty or hypogonadotropic hypogonadism.
    Reinehr T, Hoffmann E, Rothermel J, Lehrian TJ, Binder G.
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):424-431. PubMed ID: 31211864
    [Abstract] [Full Text] [Related]

  • 10. Ascertainment and treatment of delayed puberty.
    Pozo J, Argente J.
    Horm Res; 2003 Sep; 60 Suppl 3():35-48. PubMed ID: 14671394
    [Abstract] [Full Text] [Related]

  • 11. [Influence of different parameters on final height of boys with constitutional delay of growth and puberty].
    Krajewska-Siuda E, Małecka-Tendera E, Krajewski-Siuda K.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Sep; 12(3):159-62. PubMed ID: 17020647
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy.
    Lawaetz JG, Hagen CP, Mieritz MG, Blomberg Jensen M, Petersen JH, Juul A.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1376-85. PubMed ID: 25594861
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Apr; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 14. Idiopathic short stature: management and growth hormone treatment.
    Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P.
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [Abstract] [Full Text] [Related]

  • 15. Constitutional delay in growth and puberty: a comparison of final height achieved between treated and untreated children.
    Ferrández Longás A, Mayayo E, Valle A, Soria J, Labarta JI.
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():345-57. PubMed ID: 8887180
    [Abstract] [Full Text] [Related]

  • 16. Constitutional delay of growth and pubertal development: growth hormone secretory pattern and possible therapy.
    Lanes R.
    Pediatrician; 1987 Jun; 14(3):168-71. PubMed ID: 3453496
    [Abstract] [Full Text] [Related]

  • 17. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
    Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L.
    J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972
    [Abstract] [Full Text] [Related]

  • 18. Male pubertal development and the role of androgen therapy.
    Richmond EJ, Rogol AD.
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
    [Abstract] [Full Text] [Related]

  • 19. Short-term testosterone treatment at bone age of 12 to 13 years does not reduce adult height in boys with constitutional delay of growth and adolescence.
    Zachmann M, Studer S, Prader A.
    Helv Paediatr Acta; 1987 Jun; 42(1):21-8. PubMed ID: 3667329
    [Abstract] [Full Text] [Related]

  • 20. Delayed pubertal growth: an overview and approach to differential diagnosis.
    Swinyard M, Lightner ES.
    Semin Adolesc Med; 1987 Dec; 3(4):227-31. PubMed ID: 3432761
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.